It is known that Tregs are suppressors of antitumor responses that disrupt the maturation of dendritic cells (DC) and prevent the activation of CD4+ effector and CD8+ cytotoxic cells in the tumor microenvironment (90). Here, CD8A is linked to neoplasm.